MedTrace Logo

An fMRI Study of Opioid-related Changes in Neural Activity

NCT02818036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2019-07-23

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to explore the effect of blocking opioids on affiliation-related neural activity.

Conditions

  • Social Acceptance

Interventions

DRUG

Naltrexone

DRUG

Placebo

Sponsors & Collaborators

  • Tristen Inagaki

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-06-21
Completion
2018-06-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02818036 on ClinicalTrials.gov